Kairos Pharma KAPA
NYSE KAPA
$0.60 +0.02 (+2.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Kairos Pharma (KAPA) EBIT (2023 - 2025)

Updated

Kairos Pharma's EBIT came in at -$5.57 million for FY2025, compared with -$2.34 million in FY2024.

Analysis

Kairos Pharma (KAPA) EBIT (2023 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put EBIT at -$2.34 million in FY2024 and -$1.71 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 7.14 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 6.43 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 3.16 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.39 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 4.27 Bn
10 Kairos Pharma 10.86 Mn -1.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.46 Mn
Mar 31, 2025 -1.27 Mn
Dec 31, 2024 -1.45 Mn
Sep 30, 2024 -383,000.00
Jun 30, 2024 -222,000.00
Mar 31, 2024 -287,000.00
Dec 31, 2023 -1.09 Mn
Sep 30, 2023 -287,000.00
API Access

Kairos Pharma EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=KAPA&period=max&api_key=YOUR_API_KEY